NASDAQ:KIDS - Nasdaq - US68752L1008 - Common Stock - Currency: USD
Record full year 2024 revenue of $204.7 million increased 38% compared to prior year, and more than doubled fourth quarter 2024 adjusted EBITDA ...
WARSAW, Ind., Feb. 19, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively...
WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively...
Term Loan and Private Placement of Convertible Notes Will Provide Up To $100 Million of Capital...
Achieves all-time high full year 2024 Revenue of $205 million representing growth of 38% Year-Over-YearInitiates guidance for record adjusted EBITDA in...
WARSAW, Ind., Jan. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively...
WARSAW, Ind., Dec. 05, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively...
Continues IPOS Corporate Partnership as Emerald-Level Sponsor...
Continues IPOS Corporate Partnership as Emerald-Level Sponsor
WARSAW, Ind., Nov. 26, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company dedicated...
Record Third Quarter 2024 Revenue Increased 37% Year-over-Year...
Record Third Quarter 2024 Revenue Increased 37% Year-over-Year
WARSAW, Ind., Oct. 23, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively...
Additional details to be discussed during the Company’s Investor Day today, September 12, 2024...
Additional details to be discussed during the Company’s Investor Day today, September 12, 2024
WARSAW, Ind., Aug. 20, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused...
KIDS stock results show that OrthoPediatrics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Record Second Quarter 2024 Revenue Increased 33% Year-over-Year...
Record Second Quarter 2024 Revenue Increased 33% Year-over-Year
Term Loan and Private Placement of Convertible Notes Will Provide Up To $100 Million of Capital
WARSAW, Ind., July 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused...